Drug Discovery: The Application of High Throughput Techniques to Target Validation and Lead Identification, Nottingham, UK
Tuesday, October 02, 2007 - Wednesday, October 03, 2007
This will be Europe's premier discovery research based Laboratory Automation conference and exhibition.
Attracting More Visitors
FREE to register and attend
More Delegates viewing Vendor Exhibition
This two-day meeting will take place on the 2nd and 3rd of October, 2007. The venue will be the East Midlands Conference Centre, Nottingham, UK.
Two Day Conference programme with World Class Keynote Speakers who will address and discuss:-
To submit an abstract contact firstname.lastname@example.org
* Assay Development for HTS & SAR
* The challenges of Sample Management
* Auto EP and Ion Channel Drug Screening
* Strategies for the Design and use of High Throughput Automation
* Cell and Protein supply for HT Screening & SAR
* GPCR: addressing Novel Pharmacologies in the HT Envrionment
Dr. Christopher Lipinski was Adjunct Senior Research Fellow at the Pfizer Global R&D; Groton CT Laboratories following his retirement in June 2002 and is now a Scientific Advisor to Melior Discovery, a drug repurposing startup.
Dr. Robert Hertzberg currently holds the position of Vice President, Screening and Compound Profiling, GSK Pharmaceuticals, responsible for approximately 200 scientists. In his current role, Dr. Hertzberg is responsible for high throughput screening and SAR screening in support of all therapeutic areas at GSK worldwide.
Further Information: http://www.elrig.org/modules.php?op=modload%26name=News%26file=article%26sid=59%26mode=thread%26order=0%26thold=0%26POSTNUKESID=85c32eba0d94192315071cdb9c66cc96